GLP-1 use is way up in a key demographic — rates are 24x higher than in 2018
This year, the number of US adults on a GLP-1 medication for weight loss reached an astonishing 11% — meaning more than one in 10 adults are on one form or another of the jab. This explosion in use of drugs like Ozempic, Wegovy and Mounjaro has happened over a very short time — about … Read more